Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02956330 · ClinicalTrials.gov registry record
Retrospective Study of the Safety and Efficacy of Patients With RVO in Subjects Who Completed Parent Study CLS1003-201
A clinical trial, sponsored by Clearside Biomedical.
- Completed
- Registry status
- 20
- Enrollment target
NCT02956330 is a clinical trial that has completed, run by Clearside Biomedical. The registered enrollment target is 20 participants.
The verdict
NCT02956330 has completed, sponsored by Clearside Biomedical.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of this non interventional retrospective study is to continue to collect data from patients following their completion of Protocol CLS 1003-201: "Safety and Efficacy of Suprachoroidal CLS-TA with Intravitreal Aflibercept in Subjects with Macular Edema Following Retinal Vein Occlusion" (ie, the parent study).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-11 |
| Est. Completion | 2017-04-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02956330
The ClinicalTrials.gov registry entry for NCT02956330 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Clearside Biomedical, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02956330 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02956330 about?
NCT02956330 is a clinical study titled "Retrospective Study of the Safety and Efficacy of Patients With RVO in Subjects Who Completed Parent Study CLS1003-201". The purpose of this non interventional retrospective study is to continue to collect data from patients following their completion of Protocol CLS 1003-201: "Safety and Efficacy of Suprachoroidal CLS-TA with Intravitreal Aflibercept in Subjects with Macular Edema Following Retinal Vein Occlusion" (i...
What is the current status of trial NCT02956330?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2016-11. Estimated completion is 2017-04-12.
Who is sponsoring clinical trial NCT02956330?
This trial is sponsored by Clearside Biomedical, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.